Nurix Therapeutics (NRIX) Other Working Capital Changes (2019 - 2025)
Historic Other Working Capital Changes for Nurix Therapeutics (NRIX) over the last 7 years, with Q4 2025 value amounting to -$13.6 million.
- Nurix Therapeutics' Other Working Capital Changes fell 220.57% to -$13.6 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$37.0 million, marking a year-over-year decrease of 2953.17%. This contributed to the annual value of -$37.0 million for FY2025, which is 2953.17% down from last year.
- As of Q4 2025, Nurix Therapeutics' Other Working Capital Changes stood at -$13.6 million, which was down 220.57% from -$7.9 million recorded in Q3 2025.
- Nurix Therapeutics' 5-year Other Working Capital Changes high stood at $50.8 million for Q4 2023, and its period low was -$16.5 million during Q3 2023.
- In the last 5 years, Nurix Therapeutics' Other Working Capital Changes had a median value of -$7.7 million in 2024 and averaged -$2.9 million.
- As far as peak fluctuations go, Nurix Therapeutics' Other Working Capital Changes tumbled by 42423.51% in 2022, and later skyrocketed by 128701.84% in 2023.
- Quarter analysis of 5 years shows Nurix Therapeutics' Other Working Capital Changes stood at $3.6 million in 2021, then crashed by 218.87% to -$4.3 million in 2022, then surged by 1287.02% to $50.8 million in 2023, then tumbled by 126.13% to -$13.3 million in 2024, then fell by 2.21% to -$13.6 million in 2025.
- Its Other Working Capital Changes was -$13.6 million in Q4 2025, compared to -$7.9 million in Q3 2025 and -$5.7 million in Q2 2025.